Patents

US 11033563 B2: Use of lactulose in the treatment of autism

Granted
2021-06-15
Filed
2019-05-24 application 16422079
Type
Utility · 16 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

A treatment for autism in which an effective amount of lactulose is administered in order to bind excess ammonia in the gastrointestinal tract, the bloodstream, and the nervous system in order to prevent or reverse ammonia poisoning caused by the administration of certain antibiotics. Lactulose molecules in the colon are fermented by certain bacteria. The fermentation process lowers the colonic pH, and ammonia, in the form of ammonium ions, is used by the bacteria for amino acid and protein synthesis. This lowers the serum ammonia levels and reduces neurotoxicity.

Source: PVGPATDIS, file of 2026-04-10 (ipg210615.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
CUREMARK, LLC 55 patentsUS company or organizationRye Brook, NYCUREMARK, LLC State business registration EXACT high confidence: identical full name and state
CUREMARK LLC Form D issuer EXACT high confidence: identical full name and state
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Joan M. FallonWhite Plains, NY61PVGPATDIS, file of 2026-04-10
Richard FeltensteinNew Rochelle, NY4PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/7016PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P1/00PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2019-07-12Assignment
Assignment of assignor's interest
FALLON, JOAN M. signed 2013-12-20
FELTENSTEIN, RICHARD signed 2013-12-20
CUREMARK, LLC RYE, NY49736/261ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.